showed that zoledronic acid-activated γδT cells enhance NK cell-mediated cytotoxicity (Figure 2) against tumor cells, a process reliant on the interaction between CD137 ligand on γδT cells and CD137 on NK cells (84). Here, TNFRSF9 is linked to neoplasm.